Transcriptomic analysis reveals global and temporal transcription changes during Candida glabrata adaptation to an oxidative environment
- 1 May 2020
- journal article
- research article
- Published by Elsevier in Fungal Biology
- Vol. 124 (5) , 427-439
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2018/20571–6)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (88881.289327/2018–01)
- Universidade de Macau
- Fundo para o Desenvolvimento das Ciências e da Tecnologia (FDCT085/2014/A2, MYRG2016-00211-FHS)
This publication has 42 references indexed in Scilit:
- Arboretum: Reconstruction and analysis of the evolutionary history of condition-specific transcriptional modulesGenome Research, 2013
- Genomewide Expression Profile Analysis of the Candida glabrata Pdr1 RegulonEukaryotic Cell, 2011
- Regulation ofCandida glabrataoxidative stress resistance is adapted to host environmentFEBS Letters, 2010
- Translational Regulation of Gene Expression during Conditions of Cell StressMolecular Cell, 2010
- From Saccharomyces cerevisiae to Candida glabrata in a few easy steps: important adaptations for an opportunistic pathogenFEMS Microbiology Letters, 2010
- Microarray and Molecular Analyses of the Azole Resistance Mechanism in Candida glabrata Oropharyngeal IsolatesAntimicrobial Agents and Chemotherapy, 2010
- Candida glabrata environmental stress response involves Saccharomyces cerevisiae Msn2/4 orthologous transcription factorsMolecular Microbiology, 2008
- High Resistance to Oxidative Stress in the Fungal Pathogen Candida glabrata Is Mediated by a Single Catalase, Cta1p, and Is Controlled by the Transcription Factors Yap1p, Skn7p, Msn2p, and Msn4pEukaryotic Cell, 2008
- A family of glycosylphosphatidylinositol-linked aspartyl proteases is required for virulence ofCandida glabrataProceedings of the National Academy of Sciences, 2007
- Candida glabrata PDR1 , a Transcriptional Regulator of a Pleiotropic Drug Resistance Network, Mediates Azole Resistance in Clinical Isolates and Petite MutantsAntimicrobial Agents and Chemotherapy, 2006